Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.98 USD | -6.29% | -3.87% | -23.20% |
Apr. 18 | Anixa Biosciences Welcomes Sanjay Juneja to Its Cancer Business Advisory Board | CI |
Mar. 12 | Anixa Biosciences, Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.20% | 95.06M | |
+1.12% | 42.59B | |
+6.77% | 40.65B | |
+45.26% | 40.57B | |
-11.96% | 26.77B | |
+6.01% | 24.81B | |
-24.92% | 18.17B | |
-3.63% | 11.7B | |
+27.16% | 12.05B | |
+7.30% | 11.1B |
- Stock Market
- Equities
- ANIX Stock
- News Anixa Biosciences, Inc.
- Anixa Biosciences : Patent on Cancer Treatment Technology Broadened by USPTO; Shares Down Early